AKT1 and cancer: Of the 23 712 isogenes, 2195 (9.26%) were related to metabolic pathways, 784 (3.31%) to pathways in cancer, 750 (3.16%) to PI3K-Akt signaling pathway, 643 (2.71%) to MAPK signaling pathway, 614 (2.59%) to neuroactive ligand-receptor interaction, and 604 (2.55%) to HTLV-I infection.